Following record recalls, Senator Bennet introduces bill to improve safety of US drugs

5 August 2010

Michael Bennet, Democrat Senator for the US state of Colorado, is making a push to protect consumers by improving the safety and quality of US drugs.

As concerns continue to mount over the safety and quality of pharmaceutical drugs sold and consumed in the USA, Senator Bennet this week introduced the Drug Safety and Accountability Act of 2010, which would enhance the ability of the Food and Drug Administration and the pharmaceutical industry to ensure US drugs are both safe and effective regardless of where they are made.

The bill would strengthen manufacturer quality standards, enhance the FDA's ability to protect Americans through improved tracking of foreign manufacturing sites, and give the FDA much-needed authority to recall potentially dangerous drugs.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight





More Features in Pharmaceutical